During the corresponding time, Sophia Genetics Sa recorded a revenue increase by 18.7 % year on year, While revenue at the Sophia Genetics Sa's corporate clients
Sophia Genetics Sa's Comment on Sales, Marketing and Customers
The company provides services to customers and patients worldwide across the healthcare ecosystem, including healthcare providers, clinical and life sciences research laboratories, and biopharmaceutical companies. Its SOPHiA DDM Platform is used for precision medicine in oncology, rare diseases, infectious diseases, cardiology, neurology, metabolism, and other disease areas. As of December 31, 2025, the company served over 993 hospital, laboratory, and biopharma customers globally, with approximately 528 core genomics customers generating revenue through various access models. Additionally, some customers use the Alamut product on a standalone basis. The company's products are commercialized as Research Use Only (RUO) and CE-IVD products, with specific regulatory labeling in the United States and the European Union. The platform supports genomic profile analysis and is utilized in clinical trials and research projects.
Sophia Genetics Sa’s Comment on Sales, Marketing and Customers
The company provides services to customers and patients worldwide across the healthcare ecosystem, including healthcare providers, clinical and life sciences research laboratories, and biopharmaceutical companies. Its SOPHiA DDM Platform is used for precision medicine in oncology, rare diseases, infectious diseases, cardiology, neurology, metabolism, and other disease areas. As of December 31, 2025, the company served over 993 hospital, laboratory, and biopharma customers globally, with approximately 528 core genomics customers generating revenue through various access models. Additionally, some customers use the Alamut product on a standalone basis. The company's products are commercialized as Research Use Only (RUO) and CE-IVD products, with specific regulatory labeling in the United States and the European Union. The platform supports genomic profile analysis and is utilized in clinical trials and research projects.
Sources:
Sophia Genetics Sa’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Sophia Genetics Sa’s corporate clients.
For your research, we’ve provided 9 tables on Sophia Genetics Sa corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
11.29 %